Skip to main content

Advertisement

Table 4 Outcomes and cost-effectiveness of secondary prevention for diabetic foot

From: The cost of illness attributable to diabetic foot and cost-effectiveness of secondary prevention in Peru

Comparison Standard care vs. sub-optimal care Standard care plus temperature monitoring vs. sub-optimal care Standard care plus temperature monitoring vs. standard care
Differences in costs (∆ costs)
Direct costs -US$2,724,815 US$22,329,464 US$25,054,279
Direct costs + Indirect costs -US$8,037,824 US$13,024,440 US$21,062,264
Differences in deaths (∆ deaths) 791 1,385 594
Differences in major amputations 2,087 3,656 1,568
Incremental cost-effectiveness ratio (∆ costs/∆ deaths)
Direct costs Cost-saving ICER = 16,124 ICER = 42,169
Direct costs + Indirect costs Cost-saving ICER = 9,405 ICER = 35,450